Nina Plückebaum

Nina Plückebaum

Auto-generated profile, based on publicly available information

Nina Plückebaum

Institute of Virology, Hannover Medical School, Hannover, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MDMalte Deseke
Malte Deseke
FRFrancesca Rampoldi
Francesca Rampoldi
ISInga Sandrock
Inga Sandrock
EBEva Maria Borst
Eva Maria Borst
HBHeike Böning
Heike Böning
IPImmo Prinz
Immo Prinz
The innate and adaptive roles of γδ T cells and their clonal γδ T cell receptors (TCRs) in immune responses are still unclear. Recent studies of γδ TCR repertoire dynamics showed massive expansion of individual Vδ1+ γδ T cell clones during viral infection. To judge whether such expansion is random or actually represents TCR-dependent adaptive immune responses, information about their cognate TCR ligands is required. Here, we used CRISPR/Cas9-mediated screening to identify HLA-DRA, RFXAP, RFX5, and CIITA as required for target cell recognition of a CMV-induced Vγ3Vδ1+ TCR, and further characterization revealed a direct interaction of this Vδ1+ TCR with the MHC II complex HLA-DR. Since MHC II is strongly upregulated by interferon-γ, these results suggest an inflammation-induced MHC-dependent immune response of γδ T cells.

14 February 2024 in mBio
Verified
Journal Article
Open access
GSGuorong Sun
Guorong Sun
KKKai Alexander Kropp
Kai Alexander Kropp
MKMarieluise Kirchner
Marieluise Kirchner
NPNina Plückebaum
Nina Plückebaum
ASAnton Selich
Anton Selich
AVAbel Viejo-Borbolla
Abel Viejo-Borbolla
Herpes simplex virus type 1 (HSV-1) must infect neurites (or nerve endings) to establish a chronic infection in neurons. Neurites are highly dynamic structures that retract or grow in the presence of repulsive or attractive proteins. Some of these proteins are released by epithelial cells in extracellular vesicles and act upon interaction with their receptor present on neurites. We show here that HSV-1 infection of epithelial cells modulated their effect on neurites, increasing neurite growth. Mechanistically, HSV-1 glycoprotein G (gG) modifies the protein composition of extracellular vesicles released by epithelial cells, increasing the amount of attractive proteins that enhance neurite outgrowth and facilitate neuronal infection. These results could inform of therapeutic strategies to block HSV-1 induction of neurite outgrowth and, thereby, neuronal infection.

22 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
CJCarina Jacobsen
Carina Jacobsen
NPNina Plückebaum
Nina Plückebaum
GSGeorge Ssebyatika
George Ssebyatika
SBSarah Beyer
Sarah Beyer
LMLucas Mendes-Monteiro
Lucas Mendes-Monteiro
AVAbel Viejo-Borbolla
Abel Viejo-Borbolla
During primary varicella zoster virus (VZV) infection, infected lymphocytes drive primary viremia, causing systemic dissemination throughout the host, including the skin. This results in cytokine expression, including interferons (IFNs), which partly limit infection. VZV also spreads from skin keratinocytes to lymphocytes prior to secondary viremia. It is not clear how VZV achieves this while evading the cytokine response. Here, we show that VZV glycoprotein C (gC) binds IFN-γ and modifies its activity, increasing the expression of a subset of IFN-stimulated genes (ISGs), including intercellular adhesion molecule 1 (ICAM1), chemokines and immunomodulatory genes. The higher ICAM1 protein level at the plasma membrane of keratinocytes facilitates lymphocyte function-associated antigen 1-dependent T cell adhesion and expression of gC during infection increases VZV spread to peripheral blood mononuclear cells. This constitutes the discovery of a strategy to modulate IFN-γ activity, upregulating a subset of ISGs, promoting enhanced lymphocyte adhesion and virus spread.

26 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
GSGeorge Ssebyatika
George Ssebyatika
KDKatja Dinkelborg
Katja Dinkelborg
LSLuisa J. Ströh
Luisa J. Ströh
FHFlorian Hinte
Florian Hinte
LCLaura Corneillie
Laura Corneillie
PBPatrick Behrendt
Patrick Behrendt
Hepatitis E virus (HEV) causes 3.3 million symptomatic cases and 44,000 deaths per year. Chronic infections can arise in immunocompromised individuals, and pregnant women may suffer from fulminant disease as a consequence of HEV infection. Despite these important implications for public health, no specific antiviral treatment has been approved to date. Here, we report combined functional, biochemical, and X-ray crystallographic studies that characterize the human antibody response in convalescent HEV patients. We identified a class of potent and broadly neutralizing human antibodies (bnAbs), targeting a quaternary epitope located at the tip of the HEV capsid protein pORF2 that contains an N-glycosylation motif and is conserved across members of the Hepeviridae. These glycan-sensitive bnAbs specifically recognize the non-glycosylated pORF2 present in infectious particles but not the secreted glycosylated form acting as antibody decoy. Our most potent bnAb protects human liver-chimeric mice from intraperitoneal HEV challenge and co-housing exposure. These results provide insights into the bnAb response to this important emerging pathogen and support the development of glycan-sensitive antibodies to combat HEV infection.